AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Dpsure M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Mediday Healthcare Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Dpsure M 50mg/500mg Tablet

Combiflex-DM 50mg/500mg tablets combine two medications to effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate severe diabetic complications like vision impairment and renal dysfunction, potentially lessening the risk of cardiovascular events. Combiflex-DM 50mg/500mg may be used as monotherapy or in conjunction with other antidiabetic treatments. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized, based on your health status, glucose readings, and concurrent medications. Consuming the tablets with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefit; discontinuation should only occur under medical supervision. Adherence to your physician's dietary and exercise plan is crucial for successful diabetes management; lifestyle choices are integral to overall control. Commonly reported side effects include nausea, vomiting, diarrhea, abdominal distress, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, particularly when used with insulin or sulfonylureas; learn to identify and manage this complication. This medication isn't suitable for all patients. Consult your doctor before commencing treatment if you have pre-existing hepatic, renal, or cardiac conditions, pancreatic issues, or consume excessive alcohol. Pregnant or lactating women should seek medical advice prior to use. Inform your physician about all medications you're taking to avoid potential drug interactions. Alcohol consumption should be minimized due to its potential to lower blood glucose. Your doctor will monitor your renal function and blood sugar levels throughout treatment.

Uses of Dpsure M 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Dpsure M 50mg/500mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Dpsure M 50mg/500mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

Common Side effects of Dpsure M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Dpsure M 50mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dpsure M 50mg/500mg tablets should be administered with food.

How Dpsure M 50mg/500mg Tablet works:

The dual-action tablet, Dpsure M (50mg/500mg sitagliptin/metformin), combines sitagliptin, which boosts insulin production, enhances insulin utilization, and decreases hepatic glucose output, with metformin, a biguanide that reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. This synergistic effect leads to superior blood glucose management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol concurrently with Dpsure M 50mg/500mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Dpsure M 50mg/500mg Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Lactation and Dpsure M 50mg/500mg tablets are likely incompatible. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Dpsure M 50mg/500mg Tablets, as dosage modification may be necessary. Consult your physician for guidance. Dpsure M 50mg/500mg Tablets are contraindicated in patients with severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

The use of Dpsure M 50mg/500mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided unless specifically directed by a physician. Medical consultation is recommended.

What if you forget to take Dpsure M 50mg/500mg Tablet :

Should you forget a Dpsure M 50mg/500mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Dpsure M 50mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Dpsure M 50mg/500mg Tablet

Dpsure M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged use of Dpsure M 50mg/500mg Tablet can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as numbness and tingling in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Dpsure M 50mg/500mg Tablets may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects such as lactic acidosis are possible. Prolonged use may also result in vitamin B12 deficiency.
Dpsure M 50mg/500mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Dpsure M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis), is a potential side effect of Dpsure M 50mg/500mg Tablet. This occurs due to a build-up of lactic acid in the blood and is rare, but avoided in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Dpsure M 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Dpsure M 50mg/500mg tablets may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis can occur. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Dpsure M 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Dpsure M 50mg/500mg tablets with alcohol is unsafe and may raise your risk of lactic acidosis.
Dpsure M 50mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excess blood lactic acid. This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Dpsure M 50mg/500mg tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia and neurological issues, such as tingling, numbness in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Dpsure M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This treatment improves blood sugar control when combined with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
Dpsure M 50mg/500mg Tablet may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Patients with known allergies to Dpsure M 50mg/500mg Tablet components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Dpsure M 50mg/500mg tablets with alcohol is unsafe and may raise the risk of lactic acidosis.
Dpsure M 50mg/500mg Tablets can cause lactic acidosis (MALA – Metformin-associated lactic acidosis), a serious medical emergency resulting from high blood lactic acid levels. This rare side effect necessitates avoiding the drug in patients with kidney disease, the elderly, or those consuming excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Dpsure M 50mg/500mg Tablet can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Dpsure M 50mg/500mg Table...
153
MRP 178
14% off